Daniel Janney, Director at Krystal Biotech, Inc. (KRYS), sold 176,668 shares at $46.61 ($8.2M) on 2019-08-29, disclosed to the SEC on 2019-09-03.
Open-market sale of $8.2M KRYS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.61 | 55,794 | $2.6M | 31.7% |
| 2 | $46.61 | 55,794 | $2.6M | 31.7% |
| 3 | $47.50 | 700 | $33K | 0.4% |
| 4 | $46.18 | 32,190 | $1.5M | 18.1% |
| 5 | $46.18 | 32,190 | $1.5M | 18.1% |
| Total | $46.46 avg | 176,668 |
| $8.2M |
| 100% |
| Filing → |
| KRYS | SELL | 2023-06-09 | $8.3M | — | Filing → |
| KRYS | SELL | 2023-05-23 | $4.8M | — | Filing → |
| KRYS | SELL | 2023-05-11 | $1.6M | — | Filing → |